Ketoflex 12/3 Diet

BEHAVIORAL2 trials

Sponsors

Istanbul Medipol University Hospital, Prof. Lutfu Hanoglu, MD

Conditions

Alzheimer Type DementiaAlzheimer's Disease (AD)ParkinsonParkinson's Disease

Unknown Phase

Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: A Clinical Study

CompletedNCT06892418

Istanbul Medipol University HospitalParkinson, Parkinson's Disease

Start: 2024-03-30End: 2024-11-30Updated: 2025-04-02

Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression

CompletedNCT06898424

Prof. Lutfu Hanoglu, MDAlzheimer's Disease (AD), Alzheimer Type Dementia

Start: 2024-03-01End: 2024-10-31Updated: 2026-03-24

Related Papers

The effect of simultaneous application of plant-rich ketogenic diet and intermittent fasting on early-to-mid-stage Alzheimer's disease: a randomised controlled trial

The journal of nutrition health & aging2026-07-24